# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Kevin Caliendo maintains Premier (NASDAQ: PINC) with a Neutral and raises the price target from $26 to $28.25.
Canaccord Genuity analyst Richard Close maintains Premier (NASDAQ:PINC) with a Hold and raises the price target from $25 to ...
Premier Inc. to be acquired by Patient Square Capital at $28.25 per share, offering shareholders a 23.8% premium.
Premier, Inc. (NASDAQ:PINC), a leading technology-enabled healthcare performance improvement company, today announced that it h...
Piper Sandler analyst Jessica Tassan maintains Premier (NASDAQ:PINC) with a Neutral and raises the price target from $24 to ...